Quốc gia: Hoa Kỳ
Ngôn ngữ: Tiếng Anh
Nguồn: NLM (National Library of Medicine)
DEXMEDETOMIDINE HYDROCHLORIDE (UNII: 1018WH7F9I) (DEXMEDETOMIDINE - UNII:67VB76HONO)
Zydus Lifesciences Limited
INTRAVENOUS
PRESCRIPTION DRUG
Dexmedetomidine hydrochloride injection is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures. None Pregnancy Category C There are no adequate and well-controlled studies of dexmedetomidine hydrochloride use in pregnant women. In an in vitro human placenta study, placental transfer of dexmedetomidine occurred. In a study in the pregnant rat, placental transfer of dexmedetomidine was observed when radiolabeled dexmedetomidine was administered subcutaneously. Thus, fetal exposure should be expected in humans, and dexmedetomidine hydrochloride should be used during pregnancy only if the potential benefits justify the potential risk to the fetus. Teratogenic effects were not observed in rats following subcutaneous administration of dexmedetomidine during the period of fetal organogenesis (from gestation day 5 to 16) with doses up to 200 mcg/kg (representing a dose approximately equal to the maximum recommended human intravenous dose based on body surface area) o
Dexmedetomidine hydrochloride Injection Dexmedetomidine hydrochloride injection 200 mcg/2 mL (100 mcg/mL) is available in 2 mL clear glass vials. The strength is based on the dexmedetomidine base. Vials are intended for single dose only. Store at 25°C (77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
Abbreviated New Drug Application
DEXMEDETOMIDINE HYDROCHLORIDE - DEXMEDETOMIDINE HYDROCHLORIDE INJECTION, SOLUTION, CONCENTRATE ZYDUS LIFESCIENCES LIMITED ---------- DEXMEDETOMIDINE HYDROCHLORIDE INJECTION PRINCIPAL DISPLAY PANEL 200 MCG/2 ML CONTAINER LABEL NDC 70771-1319-1 Dexmedetomidine Hydrochloride Injection 200 mcg/2 mL (100 mcg/mL) For Intravenous Infusion Use MUST BE DILUTED 2 mL Single-Dose Vial Rx only Zydus Pharmaceuticals PRINCIPAL DISPLAY PANEL - 200 MCG/2 ML CARTON LABEL NDC 70771-1319-7 Dexmedetomidine Hydrochloride Injection 200 mcg/2 mL (100 mcg/mL) For Intravenous Infusion Use MUST BE DILUTED 25 X 2 mL Single-Dose Vials Rx only Zydus Pharmaceuticals DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride injection, solution, concentrate PRODUCT INFORMATION PRODUCT TYPE HUMAN PRESCRIPTION DRUG ITEM CODE (SOURCE) NDC:70771-1319 ROUTE OF ADMINISTRATION INTRAVENOUS ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRENGTH DEXMEDETOMIDINE HYDROCHLORIDE (UNII: 1018WH7F9I) (DEXMEDETOMIDINE - DEXMEDETOMIDINE 100 ug Zydus Lifesciences Limited UNII:67VB76HONO) DEXMEDETOMIDINE in 1 mL INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH SODIUM CHLORIDE (UNII: 451W47IQ8X) 9 mg in 1 mL WATER (UNII: 059QF0KO0R) PACKAGING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:70771- 1319-7 25 in 1 CARTON 06/14/2018 1 NDC:70771- 1319-1 2 mL in 1 VIAL; Type 0: Not a Combination Product MARKETING INFORMATION MARKETING CATEGORY APPLICATION NUMBER OR MONOGRAPH CITATION MARKETING START DATE MARKETING END DATE ANDA ANDA206798 06/14/2018 LABELER - Zydus Lifesciences Limited (918596198) REGISTRANT - Zydus Lifesciences Limited (918596198) ESTABLISHMENT NAME ADDRESS ID/FEI BUSINESS OPERATIONS Zydus Lifesciences Limited 918596198 ANALYSIS(70771-1319) , MANUFACTURE(70771-1319) Revised: 10/2022 Đọc toàn bộ tài liệu